While we’re catching a high-risk population through preventive screenings, we are also identifying an entirely separate high-risk population: children of the patients that were just screened and found to have high risk polyps such as greater than 1 cm or with certain advanced characteristics.

Nvidia and Medtronic recently announced a collaboration focused on embedding AI into medical devices. The two companies plan to create marketplace for AI applications that will allow developers and clinicians to develop their own algorithms to use on Medtronic’s medical devices.

Seventy-one percent of reusable medical scopes deemed ready for use on patients tested positive for bacteria at three major U.S. hospitals, according to a new study published in the American Journal of Infection Control.

The Pure-VU system from MOTUS GI allows physicians to clean an inadequately prepped colon during a colonoscopy such that they can see existences of what could be cancerous polyps.

Though a second collaboration has occurred, Check-Cap is still far behind its own timeline for gaining regulatory go-aheads for its camera-in-a-pill device.